Learn about current FDA programs that involve health professionals.
As you and other health care providers work on the front lines of the COVID-19 pandemic, we want you to know we are here to help you and your patients through this critical time. We recognize your concerns about protecting the safety of your patients, yourselves, and your families.
While our nation’s emphasis is on combating the virus, protecting health care providers and facilitating access to critical medical products continue to be a top priority for the FDA.
How to Report Adverse Events to FDA MedWatch
Health professionals, consumers and patients can voluntarily report observed or suspected adverse events for human medical products to FDA. Voluntary reporting can help FDA identify unknown risk for approved medical products.Learn More
FDA Expert Commentary and Interview Series on Medscape
FDA Updates Regulations on Mammography - June 2019Learn More
Ummzy LLC Issues Voluntary Nationwide Recall of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night Due to the Presence of Undeclared Tadalafil Sildenafil & Vardenafil
Green Pharmaceuticals Inc Issues Voluntary Nationwide Recall of SnoreStop NasoSpray Due to Microbial Contamination
Potential for Internal Pump Malfunction in the Medtronic HVAD System – Letter to Health Care Providers
Contact the Stakeholder Engagement Staff
Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO32-5367
Silver Spring, MD 20993